Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?

被引：34
|
作者：
Nikpour, M. [1 ,2 ,3 ,4 ]
Gladman, D. D. [1 ,2 ]
Urowitz, M. B. [1 ,2 ]
机构：
[1] Univ Toronto, Lupus Clin, Toronto, ON M5S 1A1, Canada
[2] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[3] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[4] St Vincents Hosp, Dept Rheumatol, Melbourne, Vic, Australia
来源：
LUPUS | 2013年 / 22卷 / 12期
关键词：
Coronary heart disease; lupus; risk factors; C-REACTIVE PROTEIN; VASCULAR EVENTS; ARTERY-DISEASE; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; WOMEN; MORTALITY; CHOLESTEROL; VARIABILITY;
D O I：
10.1177/0961203313493031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Coronary heart disease (CHD) is a major cause of mortality in systemic lupus erythematosus (SLE). This 'accelerated atherosclerosis' is due to a combination of traditional risk factors such as hypertension and hyperlipidemia, and also disease-related factors such as chronic inflammation. Recent work has provided valuable insights into the relative contribution of various risk factors and also identified novel risk factors. An understanding of risk factors is fundamental to the prevention of CHD in SLE. In this review, we will discuss the role of risk factors for CHD in SLE and offer some strategies for their assessment and management.
引用
收藏
页码：1243 / 1250
页数：8
相关论文
共 50 条
  • [31] Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review
    Tselios, Konstantinos
    Sheane, Barry J.
    Gladman, Dafna D.
    Urowitz, Murray B.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (01) : 54 - 65
  • [32] Optimal Monitoring for Coronary Heart Disease Risk in Systemic Lupus Erythematosus Patients: a Systematic Review
    Tselios, Konstantinos
    Sheane, Barry J.
    Gladman, Dafna
    Urowitz, Murray
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus
    Bessant, R
    Hingorani, A
    Patel, L
    MacGregor, A
    Isenberg, DA
    Rahman, A
    RHEUMATOLOGY, 2004, 43 (07) : 924 - 929
  • [34] Systemic lupus erythematosus. "What do we know and wher eare we heading?"
    Alarcon Riquelme, Marta Eugenia
    REUMATOLOGIA CLINICA, 2010, 6 (01): : 1 - 2
  • [35] Cardiovascular risk factors and coronary calcification (CC) in systemic lupus erythematosus
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S287 - S287
  • [36] What do lupus specialists believe about managing conventional cardiovascular risk factors in patients with systemic lupus erythematosus?
    Rahman, A.
    Bessant, R.
    Isenberg, D. A.
    LUPUS, 2006, 15 (10) : 697 - 699
  • [37] RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    PETRI, M
    PEREZGUTTHANN, S
    SPENCE, D
    HOCHBERG, MC
    AMERICAN JOURNAL OF MEDICINE, 1992, 93 (05): : 513 - 519
  • [38] Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity
    Kiani, Adnan N.
    Magder, Laurence
    Petri, Michelle
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (07) : 1300 - 1306
  • [39] Cardiac involvement and coronary artery disease (CAD) risk factors in children with systemic lupus erythematosus
    Agle, L
    Wagenfuhr, J
    Moyses, RL
    Kiss, MHB
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S262 - S262
  • [40] RISK FACTORS FOR HOSPITALIZATION IN SYSTEMIC ERYTHEMATOSUS LUPUS (SLE). WHAT IS AT STAKE IN THE FIRST YEAR OF THE DISEASE?
    Schiliro, D.
    Trentin, F.
    Signorini, V.
    Elefante, E.
    Stagnaro, C.
    Carli, L.
    Ferro, F.
    Zucchi, D.
    Maffi, M.
    Gualtieri, L.
    Valevich, A.
    Cascarano, G.
    Tani, C.
    Mosca, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1497 - 1497
12345